Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
about
Organic Nanomaterials and Their Applications in the Treatment of Oral DiseasesInhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.Time for a change: addressing R&D and commercialization challenges for antibacterialsActivity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosisTransport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilmsStudy of ocular drug delivery system using drug-loaded liposomesLiposomal encapsulated rhodomyrtone: a novel antiacne drugPreparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains.A novel liposomal drug delivery system for PMMA bone cementsTobramycin for the treatment of bacterial pneumonia in children.Liposomal antibiotics for the treatment of infectious diseases.Nanoliposome-based antibacterial drug delivery.Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients.Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.Vancomycin-eluting niosomes: a new approach to the inhibition of staphylococcal biofilm on abiotic surfaces.Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities.Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa.Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid.Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa.Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa.The effect of aminoglycoside antibiotics on the thermodynamic properties of liposomal vesicles.Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.Nanoparticle-based local antimicrobial drug delivery.Sustained broad-spectrum antibacterial effects of nanoliposomes loaded with silver nanoparticles.
P2860
Q26766613-9A162494-191E-46EC-97C1-298602BC79F0Q28077482-5C1A791C-D246-4858-975C-31F412D0EAD7Q28085068-50D6A74D-F289-4891-9CB8-7357AF5FFEC8Q28475562-316EC596-EC14-47D0-9BDC-CC47A7D4821BQ28535144-1F44B8D1-7A51-476F-8E88-856316979A30Q34448362-ED9C7E5C-96C5-45D4-BCAA-40DEA9268571Q36896284-612F6521-672F-4E1C-AE56-B5D43344F5AFQ37159968-2B8FEC2D-57DC-4BB7-992E-7D28C1ED358CQ37371134-4FBBEDD8-3B52-4B5E-93BC-62CA6382CC02Q37980230-CE8C1AD0-EB87-47E6-AF0C-4C31D158BB52Q38124144-2E8B2E3B-6EDD-4930-8771-6C64229B6A22Q38169247-BDA3D591-0810-480A-B752-D81E75BCDA20Q38214155-298B5E7B-3511-4799-AA5D-5BCB1967115CQ38340865-22D4B7C5-D940-442D-B432-521EBC7C34FAQ38938501-5E89F538-BE1B-4927-ACF6-81BA5DF659CEQ39172960-8C2379F6-5FBB-4F8A-AFE8-32DEC284F51BQ39308123-EE365DF4-94B9-4C49-BB20-D8A70B5534B4Q39672174-C7516EB4-D428-4282-B1B3-087FA1D8E3F7Q39927795-7B238D25-4779-40A9-9CA5-352F31766DB7Q41885249-D61EDA9D-432E-491A-BEFA-E37100EC8D2CQ42731688-F89B6C88-6483-46F6-B7EE-4DDE8BDCEB6EQ44573552-B81D2517-6728-4EEF-89A1-46358406EE51Q44773244-26BC0D87-4E01-43B3-A945-2E335A2EC2E1Q44855920-994BD3C6-051F-46B0-8E3B-AF65C800BF0EQ44877341-C3CE448F-1A76-46B7-814F-D9547ED5F547Q44877819-E150435E-7FC6-4F43-B8A4-58C818A2135FQ44885425-456C693F-5582-4102-BBBB-A1A601785BD9Q46202238-77C7FF14-FC93-4151-AEAA-DD50CD13F126Q46223691-3DDDAFE8-D3F8-4352-B8B4-283A45884939Q50010135-BF74162F-68E8-4246-B9CA-1A66DC4A8DC4
P2860
Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanism of enhanced activity ...... ins of Pseudomonas aeruginosa.
@en
Mechanism of enhanced activity ...... ins of Pseudomonas aeruginosa.
@nl
type
label
Mechanism of enhanced activity ...... ins of Pseudomonas aeruginosa.
@en
Mechanism of enhanced activity ...... ins of Pseudomonas aeruginosa.
@nl
prefLabel
Mechanism of enhanced activity ...... ins of Pseudomonas aeruginosa.
@en
Mechanism of enhanced activity ...... ins of Pseudomonas aeruginosa.
@nl
P2860
P50
P356
P1476
Mechanism of enhanced activity ...... ains of Pseudomonas aeruginosa
@en
P2093
Ali O Azghani
Clement Mugabe
P2860
P304
P356
10.1128/AAC.01547-05
P407
P577
2006-06-01T00:00:00Z